胃癌晚期合并难治性肺炎患者抗感染治疗的药学监护
x

请在关注微信后,向客服人员索取文件
| 篇名: | 胃癌晚期合并难治性肺炎患者抗感染治疗的药学监护 |
| TITLE: | The pharmaceutical care during anti-infective therapy for a patient with advanced gastric cancer and refractory pneumonia |
| 摘要: | 目的 探讨临床药师在胃癌晚期合并难治性肺炎患者抗感染治疗中的药学监护作用。方法临床药师参与1例胃癌术后继发难治性肺炎患者的抗感染诊疗,结合患者重症监护病房有创通气、持续镇痛镇静、排痰障碍、气道大量黏稠分泌物等临床特征,以及支气管肺泡灌洗液(BALF)宏基因组新一代测序结果,开展个体化药学监护。结果BALF测序检出携带SHV-11耐药基因肺炎克雷伯菌(序列数1018653、相对丰度93.84%、覆盖度82.74%),临床药师提出全身抗感染药物联合支气管肺泡灌洗局部病灶干预的综合方案,并开展个体化药学监护。医师采纳该干预方案。患者住院期间累计完成24次支气管肺泡灌洗,先后采用哌拉西林/他唑巴坦、美罗培南单药治疗,后调整为美罗培南分别联合替加环素、多黏菌素B治疗。经综合干预后,患者体温恢复正常,呼吸道症状明显缓解,感染指标显著下降,肺部影像学炎性病灶逐步吸收,最终病情好转出院。结论临床药师依据患者各项检查结果分析耐药机制,协助医师制定并动态调整抗菌药物联合高频次支气管肺泡灌洗方案,保障了患者的疗效与安全,为肿瘤晚期合并难治性肺炎患者的抗感染治疗提供了新思路。 |
| ABSTRACT: | OBJECTIVE To explore the role of clinical pharmacists in pharmaceutical care during anti-infective therapy for a patient with advanced gastric cancer complicated by refractory pneumonia.METHODS Clinical pharmacists participated in the anti-infective diagnosis and treatment of a patient with refractory pneumonia secondary to gastric cancer surgery. Based on the patient’s clinical characteristics in the intensive care unit, including invasive mechanical ventilation, continuous analgesia and sedation, impaired sputum expectoration, and a large amount of viscous airway secretions, as well as the results of metagenomic next-generation sequencing(mNGS) of bronchoalveolar lavage fluid(BALF), individualized pharmaceutical care was carried out.RESULTS mNGS of BALF detected Klebsiella pneumoniae carrying the SHV-11 resistance gene (sequence number of 1 018 653, relative abundance of 93.84%, coverage of 82.74%). The clinical pharmacist proposed a comprehensive regimen of systemic anti-infective drugs combined with local lesion intervention by bronchoalveolar lavage and provided individualized pharmaceutical care, which was adopted by the physicians. During hospitalization, the patient underwent a total of 24 bronchoalveolar lavage procedures and was successively treated with piperacillin/tazobactam and meropenem monotherapy, followed by adjustment to meropenem combined with tigecycline and polymyxin B, respectively. After the comprehensive intervention, the patient’s body temperature returned to normal, respiratory symptoms were significantly relieved, infection indicators decreased markedly, and pulmonary imaging showed gradual absorption of the inflammatory lesions; the patient eventually improved and was discharged.CONCLUSIONS Based on the patient’s examination results, the clinical pharmacist analyzed the mechanisms of drug resistance and assisted the physicians in formulating and dynamically adjusting a regimen of systemic antimicrobials combined with high-frequency bronchoalveolar lavage, thereby ensuring the efficacy and safety of treatment and providing a new approach for anti-infective therapy in patients with advanced gastric cancer complicated by refractory pneumonia. |
| 期刊: | 2026年第37卷第21期 |
| 作者: | 罗钟玲;白浩 |
| AUTHORS: | LUO Zhongling,BAI Hao |
| 关键字: | 难治性肺炎;肿瘤晚期;肺炎克雷伯菌;抗感染治疗;支气管肺泡灌洗;药学监护 |
| KEYWORDS: | advanced tumor; Klebsiella pneumoniae ;anti-infective therapy;bronchoalveolar lavage;pharmaceutical care |
| 阅读数: | 2 次 |
| 本月下载数: | 0 次 |
* 注:未经本站明确许可,任何网站不得非法盗链资源下载连接及抄袭本站原创内容资源!在此感谢您的支持与合作!
返回
加入收藏










